Evidence map›Paper›PMID 37655449›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2023

Aryl derivatives of 3

Anastasija Balašova, Aleksandrs Pustenko, Alessio Nocentini, Daniela Vullo, Claudiu T Supuran, Raivis Žalubovskis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Anastasija BalašovaLatvian Institute of Organic Synthesis, Riga, Latvia.ORCID 0000-0002-1185-1922
Aleksandrs PustenkoLatvian Institute of Organic Synthesis, Riga, Latvia.ORCID 0000-0003-4930-7372
Alessio NocentiniDepartment of Neurofarba, Section of Pharmaceutical and Nutraceutical Sciences, Florence, Italy.ORCID 0000-0003-3342-702X
Daniela VulloDepartment of Neurofarba, Section of Pharmaceutical and Nutraceutical Sciences, Florence, Italy.ORCID 0000-0002-1352-1900
Claudiu T SupuranDepartment of Neurofarba, Section of Pharmaceutical and Nutraceutical Sciences, Florence, Italy.ORCID 0000-0003-4262-0323
Raivis ŽalubovskisLatvian Institute of Organic Synthesis, Riga, Latvia.ORCID 0000-0002-9471-1342
Ministry of Science, Technology and Innovation · MYRiga Technical University · LVLatvijas Organiskās Sintēzes Institūts · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A range of 3

Indexed as

Carbonic AnhydrasesNeoplasmsCarbonic Anhydrase ICytosolOxidesProtein IsoformsCarbonic Anhydrase ICarbonic AnhydrasesOxidesProtein Isoformsanticancerbenzoxaphosphepine 2-oxideCarbonic anhydraseisoform-selective inhibitorsSuzuki reaction

Identifiers

PMID37655449
PMCPMC10478600
OpenAlexW4386347908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.